Regulatory molecules required for nucleotide-sensing Toll-like receptors

被引:64
作者
Saitoh, Shin-Ichiroh [1 ]
Miyake, Kensuke [1 ]
机构
[1] Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan
关键词
TLR7; TLR9; autoimmune disease; trafficking; UNC93B1; PRAT4A; PLASMACYTOID DENDRITIC CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DOUBLE-STRANDED-RNA; INTERFERON-ALPHA INDUCTION; ANTIGEN-PRESENTING CELLS; SHOCK-PROTEIN GP96; ACTIVATE B-CELLS; INNATE IMMUNITY; I INTERFERON; CPG MOTIFS;
D O I
10.1111/j.1600-065X.2008.00729.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLRs) play an important role in innate immune responses against bacteria and viruses. TLRs localize either on the cell surface or in intracellular vesicular compartments. The cell-surface TLRs, including TLR1, TLR2, TLR4, and TLR6, recognize microbial membrane lipids, whereas TLR3, TLR7, TLR8, and TLR9 recognize pathogen-derived nucleotides in intracellular compartments. TLR7 and TLR9 respond to host-derived nucleotides as well, and they have been implicated in a variety of autoimmune diseases. Safety mechanisms are required to avoid detrimental autoimmune responses. TLR7 and TLR9 are sequestered in the endoplasmic reticulum (ER) in a resting state and traffic to endolysosomes upon ligand-induced stimulation. Sequestration in the ER is a mechanism controlling TLR7/9 responses. A chaperone, gp96, in the ER is reported to regulate TLR7/9 maturation. gp96 is associated with TLR9 and is required for ligand-induced activation of TLR7/9. Two molecules in the ER are reported to regulate TLR7/9 trafficking to endolysosomes. PRAT4A (a protein associated with TLR4 A) is associated with TLR9 and is required for ligand-induced trafficking of TLR9 to endolysosomes. UNC93B1 is specifically associated with TLR3, TLR7, TLR9, and TLR13 and regulates ligand-induced trafficking of TLR7 and TLR9 from the ER to endolysosomes. These molecules are potential therapeutic targets for controlling dysregulated TLR7/9 responses in autoimmune diseases.
引用
收藏
页码:32 / 43
页数:12
相关论文
共 163 条
[1]  
Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
[2]  
2-U
[3]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[4]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[5]   CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes [J].
Andrade, Rosa M. ;
Wessendarp, Matthew ;
Gubbels, Marc-Jan ;
Striepen, Boris ;
Subauste, Carlos S. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09) :2366-2377
[6]   Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis [J].
Asagiri, Masataka ;
Hirai, Toshitake ;
Kunigami, Toshihiro ;
Kamano, Shunya ;
Gober, Hans-Juergen ;
Okamoto, Kazuo ;
Nishikawa, Keizo ;
Latz, Eicke ;
Golenbock, Douglas T. ;
Aoki, Kazuhiro ;
Ohya, Keiichi ;
Imai, Yuuki ;
Morishita, Yasuyuki ;
Miyazono, Kohei ;
Kato, Shigeaki ;
Saftig, Paul ;
Takayanagi, Hiroshi .
SCIENCE, 2008, 319 (5863) :624-627
[7]   Treatment of lupus-prone of TLR7 and TLR9 leads to mice with a dual inhibitor reduction of autoantibody production and amelioration of disease symptoms [J].
Barrat, Franck J. ;
Meeker, Thea ;
Chan, Jean H. ;
Guiducci, Cristiana ;
Cofftnan, Robert L. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (12) :3582-3586
[8]   Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA [J].
Barton, GM ;
Kagan, JC ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2006, 7 (01) :49-56
[9]   The molecular structure of the Toll-like receptor 3 ligand-binding domain [J].
Bell, JK ;
Botos, I ;
Hall, PR ;
Askins, J ;
Shiloach, J ;
Segal, DM ;
Davies, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) :10976-10980
[10]   Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies [J].
Bengtsson, AA ;
Sturfelt, G ;
Truedsson, L ;
Blomberg, J ;
Alm, G ;
Vallin, H ;
Rönnblom, L .
LUPUS, 2000, 9 (09) :664-671